Log In
BCIQ
Print this Print this
 

WST-2

  Manage Alerts
Collapse Summary General Information
Company WinSanTor Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionUndisclosed
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationNeuropathy
Indication DetailsTreat diabetic neuropathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today